{"metadata": {"source": "pubchem", "title": "Morphine | C17H19NO3 | CID 5288826 - PubChem", "description": "Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5288826", "drug": "Morphine", "cid": 5288826, "char_count": 201355, "word_count": 27013, "doc_id": "doc_53", "num_chunks": 298, "chunk_id": "53::chunk_142", "document_index": 53, "latency_s": 1.4332315999927232, "prompt_toks": 53771, "completion_toks": 97, "relevance_score": 0.0067975316}, "content": "Drug: Morphine | cid: 5288826\nSource: pubchem | Source description: Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    A prospective cohort study of postcesarean pain control compared (1) morphine PCA and scheduled ibuprofen for the first 12 hours followed by continued scheduled ibuprofen with hydrocodone-acetaminophen as needed to a multimodal pain management regimen consisting of (2) acetaminophen 1000 mg orally every 8 hours, ketorolac 30 mg IV once initially, then 15 mg IV every 8 hours for 24 hours, then ibuprofen 600 mg orally every 8 hours for the remainder of the postoperative course with opioids given only as needed. Of women who planned to exclusively breastfeed on admission, fewer women used formula prior to discharge in the multimodal group compared to the traditional group (9% vs. 12%).\n\nA study compared 2 mg of epidermal morphine to saline given within 1 hour after vaginal delivery. No differences were found between the two groups in the rates of any breastfeeding or exclusive breastfeeding at 1 or 6 weeks postpartum.\n\n◈ What is morphine?\n\n\n                    Context: \n                    This chunk summarizes clinical studies related to morphine use in postpartum and post-vaginal delivery pain management, highlighting its effects on breastfeeding rates and postpartum care strategies. It provides specific comparisons of multimodal pain control regimens and their impact on breastfeeding versus formula use, and discusses efficacy and safety data on epidural morphine administration. As part of the full webpage, it emphasizes morphine’s role in obstetric pain treatment and its relevance to breastfeeding safety and clinical outcomes.\n                "}
{"metadata": {"source": "pubchem", "title": "Morphine | C17H19NO3 | CID 5288826 - PubChem", "description": "Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5288826", "drug": "Morphine", "cid": 5288826, "char_count": 201355, "word_count": 27013, "doc_id": "doc_53", "num_chunks": 298, "chunk_id": "53::chunk_56", "document_index": 53, "latency_s": 1.2842539999983273, "prompt_toks": 53644, "completion_toks": 65, "relevance_score": 0.0045032725}, "content": "Drug: Morphine | cid: 5288826\nSource: pubchem | Source description: Morphine | C17H19NO3 | CID 5288826 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    experts, stakeholders, the public, peer reviewers, and a federally chartered advisory committee. It is important that patients receive appropriate pain treatment with careful consideration of the benefits and risks of treatment options. This guideline is intended to improve communication between clinicians and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder, overdose, and death.\n\n\n                    Context: \n                    This excerpt discusses guidelines designed to enhance communication between clinicians and patients regarding opioid therapy for chronic pain, aiming to improve safety, efficacy, and reduce risks such as addiction and overdose. It is relevant within the webpage's comprehensive overview of morphine, a key opioid, highlighting regulatory and clinical considerations important for medical and safety information retrieval.\n                "}
{"metadata": {"source": "psychonaut", "title": "Morphine - PsychonautWiki", "description": "Morphine is a naturally-occurring opioid substance of the morphinan class. It is one of the natural plant alkaloids found in opium, along side codeine which is extracted from Papaver somniferum (also known as the poppy plant).[6] Additionally, it is considered to be the prototype opiate (i.e. the standard to which others are compared) and the basis of derivatives such as codeine, diacetylmorphine (heroin), and hydrocodone.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Morphine", "drug": "Morphine", "cid": 5288826, "char_count": 29485, "word_count": 4133, "doc_id": "doc_90", "num_chunks": 38, "chunk_id": "90::chunk_1", "document_index": 90, "latency_s": 0.9185287000000244, "prompt_toks": 8278, "completion_toks": 48, "relevance_score": 0.0042812545}, "content": "Drug: Morphine | cid: 5288826\nSource: psychonaut | Source description: Morphine is a naturally-occurring opioid substance of the morphinan class. It is one of the natural plant alkaloids found in opium, along side codeine which is extracted from Papaver somniferum (also known as the poppy plant).[6] Additionally, it is considered to be the prototype opiate (i.e. the standard to which others are compared) and the basis of derivatives such as codeine, diacetylmorphine (heroin), and hydrocodone.\n\n                    Text: \n                    Morphine  Purpose Chemical Nomenclature Common names Morphine, MS-Contin, Oramorph, Zomorph, Sevredol, Duramorph Substitutive name Morphine Systematic name (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol Class Membership Psychoactive class Opioid Chemical class Morphinan Routes of Administration WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section . ⇣ Oral Dosage Bioavailability 35% - 40% Threshold < 10 mg Light 10 - 15 mg Common 15 - 20 mg Strong 20 - 30 mg Heavy 30 mg + Duration Total 4 - 6 hours Onset 10 - 30 minutes Come up 20 - 40 minutes Peak 2 - 3 hours Offset 1 - 2 hours After effects 12h ⇣ Intravenous Dosage Bioavailability 100% Threshold < 3.33 mg Light 3.33 - 5 mg Common 5 - 7.5 mg Strong 7.5 - 10 mg Heavy 10 mg + [2] [3] [4] [5] Duration Total 4 - 5 hours Onset 0 - 30 seconds Come up 2 - 5 minutes Peak 1.5 - 2.5 hours Offset 60 - 90 minutes After\n\n\n                    Context: \n                    This chunk provides detailed definition, common names, chemical nomenclature, routes of administration, and dosage information for morphine, complementing the broader discussion of its pharmacology, effects, and safety in the full document on this powerful opioid.\n                "}
